https://www.selleckchem.com/pr....oducts/sch-900776.ht
58, p0.001) on linear regression analysis. Age and ochronosis scores were significantly related to Vmax on multiple regression analysis (p0.005). Nitisinone decreased sHGA, 24-h urine HGA (uHGA , ochronosis scores and AKUSSI significantly at all visits post-nitisinone. Nitisinone decreased Vmax change scores at final visit comparison, with a similar pattern at earlier visits. Aortic valve disease is highly prevalent in this NAC cohort, and strongly associated with ochronosis and disease severity. Nitisinone decreases ochronos